All individual trials at Allena Pharmaceuticals

An AllTrials project

All individual trials at Allena Pharmaceuticals

0 out of 6

0.0%

$88,896,196

$0

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
overdue	Allena Pharmaceuticals	NCT02547805	A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of ALLN-177 Treatment Over 28 Days in Patients With Secondary Hyperoxaluria and Kidney Stones [pACT]	2017-01-31	2619
overdue	Allena Pharmaceuticals	NCT03456830	Evaluate the Safety and Efficacy of ALLN-177 in Patients With Enteric Hyperoxaluria: A Phase III Randomized, Placebo-Controlled Study	2019-09-30	1646
overdue	Allena Pharmaceuticals	NCT03391804	Pilot Study of ALLN-177 in Adult and Pediatric Subjects Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia	2019-12-13	1572
overdue	Allena Pharmaceuticals	NCT04987242	An Inpatient, Placebo-Controlled Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects	2022-03-02	763
overdue	Allena Pharmaceuticals	NCT03847090	Establishing the Safety and Efficacy of Reloxaliase (Oxalate Decarboxylase) in Patients With Enteric Hyperoxaluria: A Phase III Randomized, Double-Blind, Placebo-Controlled Study (URIROX-2)	2022-05-19	685
overdue	Allena Pharmaceuticals	NCT04987294	A Randomized, Double-Blind, Placebo-Controlled Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects With Gout and Mild to Moderate Chronic Kidney Disease	2022-09-02	579

Download this data